Recent gene therapy approvals, including therapies for ocular and central nervous system disorders, have demonstrated AAV as an effective technology for genetic disease treatment. Biopharma 101 by ...
Roche has exercised its option to license a novel capsid from Dyno Therapeutics for use in a gene therapy program for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback